Ramiah Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-19,901
Closed -$856K 92
2021
Q3
$856K Sell
19,901
-969
-5% -$42.9K 0.61% 40
2021
Q2
$817K Sell
20,870
-56
-0.3% -$2.18K 0.59% 36
2021
Q1
$758K Buy
+20,926
New +$743K 0.57% 38

Other funds holding PFE

Ramiah Investment Group's PFE Position: Q4 2021 in Review

Ramiah Investment Group sold out of Pfizer (PFE) in Q4 2021, closing a stake of 19,901 shares — an estimated $856K sold.

Ramiah Investment Group first reported a position in PFE in Q1 2021 and held it in 3 quarters. The position peaked at $856K in Q3 2021. 3,262 funds tracked by Wall St. Rank hold PFE as of Q4 2021.

  • Ramiah Investment Group reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
  • Ramiah Investment Group sold 19,901 Pfizer shares in Q4 2021, an estimated $856K.
  • Ramiah Investment Group first reported a position in Pfizer in Q1 2021 and held it in 3 quarters.
  • Ramiah Investment Group's Pfizer position peaked at $856K in Q3 2021.
  • 3,262 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.

Based on Ramiah Investment Group's 13F filing for Q4 2021, filed 29 May 2026.